These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 12599340)
41. New dietary ingredient notifications: a comprehensive review and strategies for avoiding FDA objections. Talati AR Food Drug Law J; 2007; 62(2):387-98. PubMed ID: 17632968 [No Abstract] [Full Text] [Related]
42. Are dietary supplements safe? Kam RY HDA Now; 2013; ():18-9. PubMed ID: 24427969 [No Abstract] [Full Text] [Related]
43. [Weighing the efficacy and safety of herbal medicine: the case of Kava-Kava]. Ben-Arye E; Reshef A; Berry E Harefuah; 2004 Aug; 143(8):592-7, 621. PubMed ID: 15523813 [TBL] [Abstract][Full Text] [Related]
44. Premarket notifications of new dietary ingredients--a ten-year review. McGuffin M; Young AL Food Drug Law J; 2004; 59(2):229-44. PubMed ID: 15318394 [No Abstract] [Full Text] [Related]
45. Sale of kava extract in some health food stores. Mills E; Singh R; Ross C; Ernst E; Ray JG CMAJ; 2003 Nov; 169(11):1158-9. PubMed ID: 14638649 [TBL] [Abstract][Full Text] [Related]
56. Who is responsible for the safety of food in a global market? Government certification v. importer accountability as models for assuring the safety of internationally traded foods. Plunkett D; Smith DeWaal C Food Drug Law J; 2008; 63(3):657-64. PubMed ID: 19031665 [No Abstract] [Full Text] [Related]
57. The government's role in advancing regenerative medicine and tissue engineering - science, safety, and ethics. Smith DS Periodontol 2000; 2006; 41():16-29. PubMed ID: 16686924 [No Abstract] [Full Text] [Related]
58. What are some resources that can help my clients sort through the conflicting information on dietary supplements? Marcason W J Am Diet Assoc; 2003 Jun; 103(6):712-3. PubMed ID: 12778042 [No Abstract] [Full Text] [Related]
59. Quality of manufacturer provided information on safety and efficacy claims for dietary supplements for colonic health. Hass DJ; Lewis JD Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):578-86. PubMed ID: 16700078 [TBL] [Abstract][Full Text] [Related]
60. The safety of kava: a regulatory perspective. Richardson WN; Henderson L Br J Clin Pharmacol; 2007 Oct; 64(4):418-20. PubMed ID: 17610532 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]